NCT00680342 Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment Status COMPLETED Phase PHASE2
NCT00676585 Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest Status COMPLETED Phase PHASE1/PHASE2
NCT00673127 Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00670982 Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00658697 Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer Status COMPLETED Phase PHASE2
NCT00636909 Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders Status COMPLETED Phase PHASE2
NCT00631072 In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer Status COMPLETED Phase PHASE1
NCT00630344 RAD001 and Bicalutamide for Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00626860 The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00625755 A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00624923 Targeting Inflammation Using Salsalate in CardioVascular Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00622401 Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 Status TERMINATED Phase PHASE1/PHASE2
NCT00620698 Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials Status COMPLETED Phase N/A
NCT00611858 Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT00601120 RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma Status WITHDRAWN Phase NA